Technical Analysis for LBPH - Longboard Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 20.98 4.33% 0.87
LBPH closed up 4.33 percent on Wednesday, March 27, 2024, on 54 percent of normal volume. It ran into resistance at its 50 day moving average.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Gapped Up Strength 0.00%
20 DMA Resistance Bearish 4.33%
NR7 Range Contraction 4.33%
Narrow Range Bar Range Contraction 4.33%
Multiple of Ten Bullish Other 4.33%

   Recent Intraday Alerts

Alert Time
50 DMA Resistance about 17 hours ago
Up 1 ATR about 19 hours ago
Rose Above 50 DMA about 19 hours ago
Up 5% about 20 hours ago
20 DMA Support about 20 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Neuroscience Epilepsy Psychiatry Neurophysiology Amyotrophic Lateral Sclerosis Neurology Nervous System Clinical Trial Product Neurological Diseases

Is LBPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.15
52 Week Low 3.6
Average Volume 661,708
200-Day Moving Average 10.70
50-Day Moving Average 21.42
20-Day Moving Average 20.25
10-Day Moving Average 20.07
Average True Range 1.52
RSI (14) 53.92
ADX 11.2
+DI 23.62
-DI 17.10
Chandelier Exit (Long, 3 ATRs) 19.95
Chandelier Exit (Short, 3 ATRs) 22.64
Upper Bollinger Bands 21.85
Lower Bollinger Band 18.66
Percent B (%b) 0.73
BandWidth 15.73
MACD Line -0.14
MACD Signal Line -0.19
MACD Histogram 0.0489
Fundamentals Value
Market Cap 691.01 Million
Num Shares 32.9 Million
EPS -2.43
Price-to-Earnings (P/E) Ratio -8.63
Price-to-Sales 0.00
Price-to-Book 13.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.13
Resistance 3 (R3) 23.13 22.41 22.77
Resistance 2 (R2) 22.41 21.86 22.41 22.65
Resistance 1 (R1) 21.70 21.52 22.05 21.70 22.53
Pivot Point 20.98 20.98 21.15 20.98 20.98
Support 1 (S1) 20.26 20.43 20.62 20.26 19.43
Support 2 (S2) 19.54 20.09 19.54 19.31
Support 3 (S3) 18.83 19.54 19.19
Support 4 (S4) 18.83